Global Pulmonary Arterial Hypertension (PAH) Market Size, Status and Forecast 2021-2027

Global Pulmonary Arterial Hypertension (PAH) Market Size, Status and Forecast 2021-2027

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Pulmonary Arterial Hypertension (PAH) Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Prostacyclin and Prostacyclin Analogs
1.2.3 SGC Stimulators
1.2.4 ERA
1.2.5 PDE-5
1.3 Market by Application
1.3.1 Global Pulmonary Arterial Hypertension (PAH) Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Clinic
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Pulmonary Arterial Hypertension (PAH) Market Perspective (2016-2027)
2.2 Pulmonary Arterial Hypertension (PAH) Growth Trends by Regions
2.2.1 Pulmonary Arterial Hypertension (PAH) Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Pulmonary Arterial Hypertension (PAH) Historic Market Share by Regions (2016-2021)
2.2.3 Pulmonary Arterial Hypertension (PAH) Forecasted Market Size by Regions (2022-2027)
2.3 Pulmonary Arterial Hypertension (PAH) Industry Dynamic
2.3.1 Pulmonary Arterial Hypertension (PAH) Market Trends
2.3.2 Pulmonary Arterial Hypertension (PAH) Market Drivers
2.3.3 Pulmonary Arterial Hypertension (PAH) Market Challenges
2.3.4 Pulmonary Arterial Hypertension (PAH) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Pulmonary Arterial Hypertension (PAH) Players by Revenue
3.1.1 Global Top Pulmonary Arterial Hypertension (PAH) Players by Revenue (2016-2021)
3.1.2 Global Pulmonary Arterial Hypertension (PAH) Revenue Market Share by Players (2016-2021)
3.2 Global Pulmonary Arterial Hypertension (PAH) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Pulmonary Arterial Hypertension (PAH) Revenue
3.4 Global Pulmonary Arterial Hypertension (PAH) Market Concentration Ratio
3.4.1 Global Pulmonary Arterial Hypertension (PAH) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pulmonary Arterial Hypertension (PAH) Revenue in 2020
3.5 Pulmonary Arterial Hypertension (PAH) Key Players Head office and Area Served
3.6 Key Players Pulmonary Arterial Hypertension (PAH) Product Solution and Service
3.7 Date of Enter into Pulmonary Arterial Hypertension (PAH) Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Pulmonary Arterial Hypertension (PAH) Breakdown Data by Type
4.1 Global Pulmonary Arterial Hypertension (PAH) Historic Market Size by Type (2016-2021)
4.2 Global Pulmonary Arterial Hypertension (PAH) Forecasted Market Size by Type (2022-2027)
5 Pulmonary Arterial Hypertension (PAH) Breakdown Data by Application
5.1 Global Pulmonary Arterial Hypertension (PAH) Historic Market Size by Application (2016-2021)
5.2 Global Pulmonary Arterial Hypertension (PAH) Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Pulmonary Arterial Hypertension (PAH) Market Size (2016-2027)
6.2 North America Pulmonary Arterial Hypertension (PAH) Market Size by Type
6.2.1 North America Pulmonary Arterial Hypertension (PAH) Market Size by Type (2016-2021)
6.2.2 North America Pulmonary Arterial Hypertension (PAH) Market Size by Type (2022-2027)
6.2.3 North America Pulmonary Arterial Hypertension (PAH) Market Size by Type (2016-2027)
6.3 North America Pulmonary Arterial Hypertension (PAH) Market Size by Application
6.3.1 North America Pulmonary Arterial Hypertension (PAH) Market Size by Application (2016-2021)
6.3.2 North America Pulmonary Arterial Hypertension (PAH) Market Size by Application (2022-2027)
6.3.3 North America Pulmonary Arterial Hypertension (PAH) Market Size by Application (2016-2027)
6.4 North America Pulmonary Arterial Hypertension (PAH) Market Size by Country
6.4.1 North America Pulmonary Arterial Hypertension (PAH) Market Size by Country (2016-2021)
6.4.2 North America Pulmonary Arterial Hypertension (PAH) Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Pulmonary Arterial Hypertension (PAH) Market Size (2016-2027)
7.2 Europe Pulmonary Arterial Hypertension (PAH) Market Size by Type
7.2.1 Europe Pulmonary Arterial Hypertension (PAH) Market Size by Type (2016-2021)
7.2.2 Europe Pulmonary Arterial Hypertension (PAH) Market Size by Type (2022-2027)
7.2.3 Europe Pulmonary Arterial Hypertension (PAH) Market Size by Type (2016-2027)
7.3 Europe Pulmonary Arterial Hypertension (PAH) Market Size by Application
7.3.1 Europe Pulmonary Arterial Hypertension (PAH) Market Size by Application (2016-2021)
7.3.2 Europe Pulmonary Arterial Hypertension (PAH) Market Size by Application (2022-2027)
7.3.3 Europe Pulmonary Arterial Hypertension (PAH) Market Size by Application (2016-2027)
7.4 Europe Pulmonary Arterial Hypertension (PAH) Market Size by Country
7.4.1 Europe Pulmonary Arterial Hypertension (PAH) Market Size by Country (2016-2021)
7.4.2 Europe Pulmonary Arterial Hypertension (PAH) Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Pulmonary Arterial Hypertension (PAH) Market Size (2016-2027)
8.2 Asia-Pacific Pulmonary Arterial Hypertension (PAH) Market Size by Type
8.2.1 Asia-Pacific Pulmonary Arterial Hypertension (PAH) Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Pulmonary Arterial Hypertension (PAH) Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Pulmonary Arterial Hypertension (PAH) Market Size by Type (2016-2027)
8.3 Asia-Pacific Pulmonary Arterial Hypertension (PAH) Market Size by Application
8.3.1 Asia-Pacific Pulmonary Arterial Hypertension (PAH) Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Pulmonary Arterial Hypertension (PAH) Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Pulmonary Arterial Hypertension (PAH) Market Size by Application (2016-2027)
8.4 Asia-Pacific Pulmonary Arterial Hypertension (PAH) Market Size by Region
8.4.1 Asia-Pacific Pulmonary Arterial Hypertension (PAH) Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Pulmonary Arterial Hypertension (PAH) Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Pulmonary Arterial Hypertension (PAH) Market Size (2016-2027)
9.2 Latin America Pulmonary Arterial Hypertension (PAH) Market Size by Type
9.2.1 Latin America Pulmonary Arterial Hypertension (PAH) Market Size by Type (2016-2021)
9.2.2 Latin America Pulmonary Arterial Hypertension (PAH) Market Size by Type (2022-2027)
9.2.3 Latin America Pulmonary Arterial Hypertension (PAH) Market Size by Type (2016-2027)
9.3 Latin America Pulmonary Arterial Hypertension (PAH) Market Size by Application
9.3.1 Latin America Pulmonary Arterial Hypertension (PAH) Market Size by Application (2016-2021)
9.3.2 Latin America Pulmonary Arterial Hypertension (PAH) Market Size by Application (2022-2027)
9.3.3 Latin America Pulmonary Arterial Hypertension (PAH) Market Size by Application (2016-2027)
9.4 Latin America Pulmonary Arterial Hypertension (PAH) Market Size by Country
9.4.1 Latin America Pulmonary Arterial Hypertension (PAH) Market Size by Country (2016-2021)
9.4.2 Latin America Pulmonary Arterial Hypertension (PAH) Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Pulmonary Arterial Hypertension (PAH) Market Size (2016-2027)
10.2 Middle East & Africa Pulmonary Arterial Hypertension (PAH) Market Size by Type
10.2.1 Middle East & Africa Pulmonary Arterial Hypertension (PAH) Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Pulmonary Arterial Hypertension (PAH) Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Pulmonary Arterial Hypertension (PAH) Market Size by Type (2016-2027)
10.3 Middle East & Africa Pulmonary Arterial Hypertension (PAH) Market Size by Application
10.3.1 Middle East & Africa Pulmonary Arterial Hypertension (PAH) Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Pulmonary Arterial Hypertension (PAH) Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Pulmonary Arterial Hypertension (PAH) Market Size by Application (2016-2027)
10.4 Middle East & Africa Pulmonary Arterial Hypertension (PAH) Market Size by Country
10.4.1 Middle East & Africa Pulmonary Arterial Hypertension (PAH) Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Pulmonary Arterial Hypertension (PAH) Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Actelion
11.1.1 Actelion Company Details
11.1.2 Actelion Business Overview
11.1.3 Actelion Pulmonary Arterial Hypertension (PAH) Introduction
11.1.4 Actelion Revenue in Pulmonary Arterial Hypertension (PAH) Business (2016-2021)
11.1.5 Actelion Recent Development
11.2 Gilead Sciences
11.2.1 Gilead Sciences Company Details
11.2.2 Gilead Sciences Business Overview
11.2.3 Gilead Sciences Pulmonary Arterial Hypertension (PAH) Introduction
11.2.4 Gilead Sciences Revenue in Pulmonary Arterial Hypertension (PAH) Business (2016-2021)
11.2.5 Gilead Sciences Recent Development
11.3 United Therapeutics
11.3.1 United Therapeutics Company Details
11.3.2 United Therapeutics Business Overview
11.3.3 United Therapeutics Pulmonary Arterial Hypertension (PAH) Introduction
11.3.4 United Therapeutics Revenue in Pulmonary Arterial Hypertension (PAH) Business (2016-2021)
11.3.5 United Therapeutics Recent Development
11.4 GlaxoSmithKline
11.4.1 GlaxoSmithKline Company Details
11.4.2 GlaxoSmithKline Business Overview
11.4.3 GlaxoSmithKline Pulmonary Arterial Hypertension (PAH) Introduction
11.4.4 GlaxoSmithKline Revenue in Pulmonary Arterial Hypertension (PAH) Business (2016-2021)
11.4.5 GlaxoSmithKline Recent Development
11.5 Pfizer
11.5.1 Pfizer Company Details
11.5.2 Pfizer Business Overview
11.5.3 Pfizer Pulmonary Arterial Hypertension (PAH) Introduction
11.5.4 Pfizer Revenue in Pulmonary Arterial Hypertension (PAH) Business (2016-2021)
11.5.5 Pfizer Recent Development
11.6 Bayer
11.6.1 Bayer Company Details
11.6.2 Bayer Business Overview
11.6.3 Bayer Pulmonary Arterial Hypertension (PAH) Introduction
11.6.4 Bayer Revenue in Pulmonary Arterial Hypertension (PAH) Business (2016-2021)
11.6.5 Bayer Recent Development
11.7 Arena
11.7.1 Arena Company Details
11.7.2 Arena Business Overview
11.7.3 Arena Pulmonary Arterial Hypertension (PAH) Introduction
11.7.4 Arena Revenue in Pulmonary Arterial Hypertension (PAH) Business (2016-2021)
11.7.5 Arena Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Pulmonary Arterial Hypertension (PAH) Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Prostacyclin and Prostacyclin Analogs
Table 3. Key Players of SGC Stimulators
Table 4. Key Players of ERA
Table 5. Key Players of PDE-5
Table 6. Global Pulmonary Arterial Hypertension (PAH) Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Pulmonary Arterial Hypertension (PAH) Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Pulmonary Arterial Hypertension (PAH) Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Pulmonary Arterial Hypertension (PAH) Market Share by Regions (2016-2021)
Table 10. Global Pulmonary Arterial Hypertension (PAH) Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Pulmonary Arterial Hypertension (PAH) Market Share by Regions (2022-2027)
Table 12. Pulmonary Arterial Hypertension (PAH) Market Trends
Table 13. Pulmonary Arterial Hypertension (PAH) Market Drivers
Table 14. Pulmonary Arterial Hypertension (PAH) Market Challenges
Table 15. Pulmonary Arterial Hypertension (PAH) Market Restraints
Table 16. Global Pulmonary Arterial Hypertension (PAH) Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Pulmonary Arterial Hypertension (PAH) Market Share by Players (2016-2021)
Table 18. Global Top Pulmonary Arterial Hypertension (PAH) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pulmonary Arterial Hypertension (PAH) as of 2020)
Table 19. Ranking of Global Top Pulmonary Arterial Hypertension (PAH) Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Pulmonary Arterial Hypertension (PAH) Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Pulmonary Arterial Hypertension (PAH) Product Solution and Service
Table 23. Date of Enter into Pulmonary Arterial Hypertension (PAH) Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Pulmonary Arterial Hypertension (PAH) Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Pulmonary Arterial Hypertension (PAH) Revenue Market Share by Type (2016-2021)
Table 27. Global Pulmonary Arterial Hypertension (PAH) Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Pulmonary Arterial Hypertension (PAH) Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Pulmonary Arterial Hypertension (PAH) Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Pulmonary Arterial Hypertension (PAH) Revenue Market Share by Application (2016-2021)
Table 31. Global Pulmonary Arterial Hypertension (PAH) Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Pulmonary Arterial Hypertension (PAH) Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Pulmonary Arterial Hypertension (PAH) Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Pulmonary Arterial Hypertension (PAH) Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Pulmonary Arterial Hypertension (PAH) Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Pulmonary Arterial Hypertension (PAH) Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Pulmonary Arterial Hypertension (PAH) Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Pulmonary Arterial Hypertension (PAH) Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Pulmonary Arterial Hypertension (PAH) Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Pulmonary Arterial Hypertension (PAH) Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Pulmonary Arterial Hypertension (PAH) Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Pulmonary Arterial Hypertension (PAH) Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Pulmonary Arterial Hypertension (PAH) Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Pulmonary Arterial Hypertension (PAH) Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Pulmonary Arterial Hypertension (PAH) Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Pulmonary Arterial Hypertension (PAH) Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Pulmonary Arterial Hypertension (PAH) Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Pulmonary Arterial Hypertension (PAH) Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Pulmonary Arterial Hypertension (PAH) Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Pulmonary Arterial Hypertension (PAH) Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Pulmonary Arterial Hypertension (PAH) Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Pulmonary Arterial Hypertension (PAH) Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Pulmonary Arterial Hypertension (PAH) Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Pulmonary Arterial Hypertension (PAH) Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Pulmonary Arterial Hypertension (PAH) Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Pulmonary Arterial Hypertension (PAH) Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Pulmonary Arterial Hypertension (PAH) Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Pulmonary Arterial Hypertension (PAH) Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Pulmonary Arterial Hypertension (PAH) Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Pulmonary Arterial Hypertension (PAH) Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Pulmonary Arterial Hypertension (PAH) Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Pulmonary Arterial Hypertension (PAH) Market Size by Country (2022-2027) & (US$ Million)
Table 63. Actelion Company Details
Table 64. Actelion Business Overview
Table 65. Actelion Pulmonary Arterial Hypertension (PAH) Product
Table 66. Actelion Revenue in Pulmonary Arterial Hypertension (PAH) Business (2016-2021) & (US$ Million)
Table 67. Actelion Recent Development
Table 68. Gilead Sciences Company Details
Table 69. Gilead Sciences Business Overview
Table 70. Gilead Sciences Pulmonary Arterial Hypertension (PAH) Product
Table 71. Gilead Sciences Revenue in Pulmonary Arterial Hypertension (PAH) Business (2016-2021) & (US$ Million)
Table 72. Gilead Sciences Recent Development
Table 73. United Therapeutics Company Details
Table 74. United Therapeutics Business Overview
Table 75. United Therapeutics Pulmonary Arterial Hypertension (PAH) Product
Table 76. United Therapeutics Revenue in Pulmonary Arterial Hypertension (PAH) Business (2016-2021) & (US$ Million)
Table 77. United Therapeutics Recent Development
Table 78. GlaxoSmithKline Company Details
Table 79. GlaxoSmithKline Business Overview
Table 80. GlaxoSmithKline Pulmonary Arterial Hypertension (PAH) Product
Table 81. GlaxoSmithKline Revenue in Pulmonary Arterial Hypertension (PAH) Business (2016-2021) & (US$ Million)
Table 82. GlaxoSmithKline Recent Development
Table 83. Pfizer Company Details
Table 84. Pfizer Business Overview
Table 85. Pfizer Pulmonary Arterial Hypertension (PAH) Product
Table 86. Pfizer Revenue in Pulmonary Arterial Hypertension (PAH) Business (2016-2021) & (US$ Million)
Table 87. Pfizer Recent Development
Table 88. Bayer Company Details
Table 89. Bayer Business Overview
Table 90. Bayer Pulmonary Arterial Hypertension (PAH) Product
Table 91. Bayer Revenue in Pulmonary Arterial Hypertension (PAH) Business (2016-2021) & (US$ Million)
Table 92. Bayer Recent Development
Table 93. Arena Company Details
Table 94. Arena Business Overview
Table 95. Arena Pulmonary Arterial Hypertension (PAH) Product
Table 96. Arena Revenue in Pulmonary Arterial Hypertension (PAH) Business (2016-2021) & (US$ Million)
Table 97. Arena Recent Development
Table 98. Research Programs/Design for This Report
Table 99. Key Data Information from Secondary Sources
Table 100. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Pulmonary Arterial Hypertension (PAH) Market Share by Type: 2020 VS 2027
Figure 2. Prostacyclin and Prostacyclin Analogs Features
Figure 3. SGC Stimulators Features
Figure 4. ERA Features
Figure 5. PDE-5 Features
Figure 6. Global Pulmonary Arterial Hypertension (PAH) Market Share by Application: 2020 VS 2027
Figure 7. Hospital Case Studies
Figure 8. Clinic Case Studies
Figure 9. Pulmonary Arterial Hypertension (PAH) Report Years Considered
Figure 10. Global Pulmonary Arterial Hypertension (PAH) Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Pulmonary Arterial Hypertension (PAH) Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Pulmonary Arterial Hypertension (PAH) Market Share by Regions: 2020 VS 2027
Figure 13. Global Pulmonary Arterial Hypertension (PAH) Market Share by Regions (2022-2027)
Figure 14. Global Pulmonary Arterial Hypertension (PAH) Market Share by Players in 2020
Figure 15. Global Top Pulmonary Arterial Hypertension (PAH) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pulmonary Arterial Hypertension (PAH) as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Pulmonary Arterial Hypertension (PAH) Revenue in 2020
Figure 17. Global Pulmonary Arterial Hypertension (PAH) Revenue Market Share by Type (2016-2021)
Figure 18. Global Pulmonary Arterial Hypertension (PAH) Revenue Market Share by Type (2022-2027)
Figure 19. North America Pulmonary Arterial Hypertension (PAH) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Pulmonary Arterial Hypertension (PAH) Market Share by Type (2016-2027)
Figure 21. North America Pulmonary Arterial Hypertension (PAH) Market Share by Application (2016-2027)
Figure 22. North America Pulmonary Arterial Hypertension (PAH) Market Share by Country (2016-2027)
Figure 23. United States Pulmonary Arterial Hypertension (PAH) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Pulmonary Arterial Hypertension (PAH) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Pulmonary Arterial Hypertension (PAH) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Pulmonary Arterial Hypertension (PAH) Market Share by Type (2016-2027)
Figure 27. Europe Pulmonary Arterial Hypertension (PAH) Market Share by Application (2016-2027)
Figure 28. Europe Pulmonary Arterial Hypertension (PAH) Market Share by Country (2016-2027)
Figure 29. Germany Pulmonary Arterial Hypertension (PAH) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Pulmonary Arterial Hypertension (PAH) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Pulmonary Arterial Hypertension (PAH) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Pulmonary Arterial Hypertension (PAH) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Pulmonary Arterial Hypertension (PAH) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Pulmonary Arterial Hypertension (PAH) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Pulmonary Arterial Hypertension (PAH) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Pulmonary Arterial Hypertension (PAH) Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Pulmonary Arterial Hypertension (PAH) Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Pulmonary Arterial Hypertension (PAH) Market Share by Region (2016-2027)
Figure 39. China Pulmonary Arterial Hypertension (PAH) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Pulmonary Arterial Hypertension (PAH) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Pulmonary Arterial Hypertension (PAH) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Pulmonary Arterial Hypertension (PAH) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Pulmonary Arterial Hypertension (PAH) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Pulmonary Arterial Hypertension (PAH) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Pulmonary Arterial Hypertension (PAH) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Pulmonary Arterial Hypertension (PAH) Market Share by Type (2016-2027)
Figure 47. Latin America Pulmonary Arterial Hypertension (PAH) Market Share by Application (2016-2027)
Figure 48. Latin America Pulmonary Arterial Hypertension (PAH) Market Share by Country (2016-2027)
Figure 49. Mexico Pulmonary Arterial Hypertension (PAH) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Pulmonary Arterial Hypertension (PAH) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Pulmonary Arterial Hypertension (PAH) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Pulmonary Arterial Hypertension (PAH) Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Pulmonary Arterial Hypertension (PAH) Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Pulmonary Arterial Hypertension (PAH) Market Share by Country (2016-2027)
Figure 55. Turkey Pulmonary Arterial Hypertension (PAH) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Pulmonary Arterial Hypertension (PAH) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Pulmonary Arterial Hypertension (PAH) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Actelion Revenue Growth Rate in Pulmonary Arterial Hypertension (PAH) Business (2016-2021)
Figure 59. Gilead Sciences Revenue Growth Rate in Pulmonary Arterial Hypertension (PAH) Business (2016-2021)
Figure 60. United Therapeutics Revenue Growth Rate in Pulmonary Arterial Hypertension (PAH) Business (2016-2021)
Figure 61. GlaxoSmithKline Revenue Growth Rate in Pulmonary Arterial Hypertension (PAH) Business (2016-2021)
Figure 62. Pfizer Revenue Growth Rate in Pulmonary Arterial Hypertension (PAH) Business (2016-2021)
Figure 63. Bayer Revenue Growth Rate in Pulmonary Arterial Hypertension (PAH) Business (2016-2021)
Figure 64. Arena Revenue Growth Rate in Pulmonary Arterial Hypertension (PAH) Business (2016-2021)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Pulmonary Arterial Hypertension (Pah) Medicine Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 04-Jan-2024        Price: US 3380 Onwards        Pages: 103

Market Overview of Global Pulmonary Arterial Hypertension (Pah) Medicine market: According to our latest research, the global Pulmonary Arterial Hypertension (Pah) Medicine market looks promising in the next 5 years. As of 2022, the global Pulmonary Arterial Hypertension (Pah) Medicine market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to ......

Global Nifedipine Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 04-Jan-2024        Price: US 3380 Onwards        Pages: 102

Market Overview of Global Nifedipine market: According to our latest research, the global Nifedipine market looks promising in the next 5 years. As of 2022, the global Nifedipine market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Nifedipine market, with a systematical de......

Global Amlodipine Besylate Market Research Report 2024

Published: 04-Jan-2024        Price: US 2900 Onwards        Pages: 115

The Amlodipine Besylate market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Amlodipine Besylate market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profil......

Pulmonary Arterial Hypertension (PAH) Drugs - Global Market Insights and Sales Trends 2024

Published: 25-Dec-2023        Price: US 3350 Onwards        Pages: 112

The global Pulmonary Arterial Hypertension (PAH) Drugs market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Pulmonary Arterial Hypertension (PAH) Drugs in various end use industries. The expanding demands from the Hospitals, Clinics and Other,, are propelling Pulmonary Arterial Hypertension (PAH) Drugs market. Inhalation, one of the segments analysed in this report, is projected to record % ......

Captopril API - Global Market Insights and Sales Trends 2024

Published: 25-Dec-2023        Price: US 3350 Onwards        Pages: 100

The global Captopril API market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Captopril API in various end use industries. The expanding demands from the Captopril Tablet, Compound Captopril Tablet and Captopril Injection,, are propelling Captopril API market. 98% Captopril API, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the......

Telmisartan - Global Market Insights and Sales Trends 2024

Published: 21-Dec-2023        Price: US 3350 Onwards        Pages: 107

The global Telmisartan market size is expected to reach US$ 3631.3 million by 2029, growing at a CAGR of 3.4% from 2023 to 2029. The market is mainly driven by the significant applications of Telmisartan in various end use industries. The expanding demands from the Hospital, Clinic and Others,, are propelling Telmisartan market. Injection, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Freeze-Dried......

Global Ambrisentan Professional Survey Report 2023, Forecast to 2028

Published: 20-Dec-2023        Price: US 3280 Onwards        Pages: 106

Ambrisentan is a drug indicated for use in the treatment of pulmonary hypertension. The peptide endothelin constricts muscles in blood vessels, increasing blood pressure. Ambrisentan, which relaxes those muscles, is an endothelin receptor antagonist, and is selective for the type A endothelin receptor. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million US......

Global Ambrisentan Market Research Report 2023, Forecast to 2028

Published: 20-Dec-2023        Price: US 2680 Onwards        Pages: 132

Ambrisentan is a drug indicated for use in the treatment of pulmonary hypertension. The peptide endothelin constricts muscles in blood vessels, increasing blood pressure. Ambrisentan, which relaxes those muscles, is an endothelin receptor antagonist, and is selective for the type A endothelin receptor. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million US......

Global Amlodipine Besylate Professional Survey Report 2023, Forecast to 2028

Published: 20-Dec-2023        Price: US 3280 Onwards        Pages: 133

Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technological advancements, new product launches, and market capital flows are compared across scenarios to demonstrate their impact over the forecast period. D......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs